Yuan L, Stoddard M, Sarkar S, Egeren DV, Mangalaganesh S, Nolan RP, Rogers MS, Hather G, White LF, Chakravarty A. (2025). The Impact of Vaccination Frequency on COVID-19 Public Health Outcomes: A Model-Based Analysis. Vaccines, 13(4)
Bayly H, Mei W, Egeren D, Stoddard M, Chakravarty A, White LF. (2023). Accuracy of Inferences About the Reproductive Number and Superspreading Potential of SARS-CoV-2 with Incomplete Contact Tracing Data. Research square
Albright C, Van Egeren D, Thakur A, Chakravarty A, White LF, Stoddard M. (2023). Antibody escape, the risk of serotype formation, and rapid immune waning: Modeling the implications of SARS-CoV-2 immune evasion. PloS one, 18(10)
Van Egeren D, Stoddard M, White LF, Hochberg NS, Rogers MS, Zetter B, Joseph-McCarthy D, Chakravarty A. (2023). Vaccines Alone Cannot Slow the Evolution of SARS-CoV-2. Vaccines, 11(4)
Van Egeren D, Stoddard M, Malakar A, Ghosh D, Acharya A, Mainuddin S, Majumdar B, Luo D, Nolan RP, Joseph-McCarthy D, White LF, Hochberg NS, Basu S, Chakravarty A. (2022). No magic bullet: Limiting in-school transmission in the face of variable SARS-CoV-2 viral loads. Frontiers in public health, (10)
Van Egeren D, Kohli K, Warner JL, Bedard PL, Riely G, Lepisto E, Schrag D, LeNoue-Newton M, Catalano P, Kehl KL, Michor F, . (2022). Genomic analysis of early-stage lung cancer reveals a role for TP53 mutations in distant metastasis. Scientific reports, 12(1)
If you’d like to update your profile, please email modifications to questions@midasnetwork.us.